Abbott’s XIENCE V Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
Posted by: DrugsNews on: 23 Sep, 2009
- In: Drugs News| News
- Comment!
Independent Study of 1,800 Patients Affirms Outstanding
Performance of XIENCE V vs. TAXUS Liberte
SAN FRANCISCO, September 23, 2009 /PRNewswire-FirstCall/ –
Late-breaking data presented today from the COMPARE trial
demonstrated…
Read more about Abbott’s XIENCE V Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- TAXUS Liberte Stent Continues to Demonstrate Significant Improvements Over TAXUS Express Stent in Small Vessels and Long Lesions
- NEVO™ Sirolimus-eluting Coronary Stent Associated With Significantly Less Chest Pain At Six Months Than Taxus(R) Liberte(R) Stent
- NEVO? Sirolimus-Eluting Coronary Stent Associated with Significantly Less Chest Pain at Six Months Than Taxus Liberte Stent
